Ceva Santé Animale (Ceva) is a French multinational veterinary pharmaceutical company created in 1999. Chaired by Dr. Marc

Prikazsky, Ceva specializes in the innovation, development, production and marketing of pharmaceutical products and vaccines

for livestock (ruminants, swine, poultry) and companion animals.

Ceva is present in 46 countries and employs over 6000 people worldwide. Ceva has achieved sustained and profitable growth

over the last 20 years, reaching over €1.5 billion in revenues and is now the global 5th largest animal health company.

Although Ceva has grown to become a global company, we have managed to retain the spirit of a small to medium-sized

enterprise. We owe our existence to the farmers, pet owners and veterinarians who support us. As a result, we are dedicated to

providing them with the best possible products and services.

Ceva’s mission, summarized in the slogan “Together, beyond animal health”, has three fundamental principles:

· Help to feed a growing population: Sustainable intensive agriculture will become an increasingly important part of the

strategy to feed 9 billion people by 2050. Ceva is working closely to its partners involved in animal protein production to

find ever more efficient ways of rearing, which place minimal stress on animals.

· Combating zoonoses: Ceva is dedicated to combating zoonoses, which carry the threat of serious pandemics,

particularly in a world of ever-increasing mobility.

· Promote the benefits of the essential link between humans and animals: In an increasingly urbanized society, Ceva

contributes in finding the best way to live in harmony with the pets.